Home › Juvenile Arthritis › Ohio
Pag-aaral pangklinika para sa Juvenile Arthritis sa Ohio
8 pag-aaral para sa Juvenile Arthritis ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Cincinnati Childrens Hospital, Cincinnati
- Univ Hosp Cleveland Medical Center, Cleveland
Nagre-recruitPhase 1
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06751238A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 3
Edad 3 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06663332Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Metrohealth Medical Center, Cleveland
- at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 21 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT02418442Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 3
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06654882Biopsychosocial Risk Influences on the Development and Generation of Early-Onset Chronic Pain
- Cincinnati Children's Hospital, Cincinnati
Nagre-recruitObservasyonal na pag-aaral
Edad 14 hanggang 26 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07602595Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 35 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07845942Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Cincinnati Childrens Hospital Medical Center /ID# 251827, Cincinnati
Nagre-recruitPhase 3
Edad 1 hanggang 17 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- MetroHealth Medical Center /ID# 262377, Cleveland
- Cleveland Clinic - Cleveland /ID# 276655, Cleveland
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06100744Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.